new_adrs_0322_0825|AYLA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_adrs_0322_0825|AYLA|1|Ayala Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Ayala Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Ayala Pharmaceuticals Inc Inventories (Quarterly) (USD)|Ayala Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Ayala Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Ayala Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Ayala Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Ayala Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Ayala Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Ayala Pharmaceuticals Inc Book Value (Quarterly) (USD)|Ayala Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Ayala Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Ayala Pharmaceuticals Inc EV to Revenues|Ayala Pharmaceuticals Inc EV to Earnings|Ayala Pharmaceuticals Inc EV to Free Cash Flow|Ayala Pharmaceuticals Inc EV to Assets (Quarterly)|Ayala Pharmaceuticals Inc PS Ratio|Ayala Pharmaceuticals Inc PE Ratio|Ayala Pharmaceuticals Inc Price to Book Value|Ayala Pharmaceuticals Inc PEG Ratio|Ayala Pharmaceuticals Inc Debt to Equity Ratio|Ayala Pharmaceuticals Inc Dividend Yield|Ayala Pharmaceuticals Inc Shareholder Yield (TTM)|Ayala Pharmaceuticals Inc Percent of Shares Outstanding Short|Ayala Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Ayala Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Ayala Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Ayala Pharmaceuticals Inc Return on Invested Capital|Ayala Pharmaceuticals Inc Quality Ratio Score|Ayala Pharmaceuticals Inc Momentum Score|Ayala Pharmaceuticals Inc Beta (1Y)|Ayala Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Ayala Pharmaceuticals Inc Institutional Investor Ownership Percentage|Ayala Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Ayala Pharmaceuticals Inc Total Employees (Annual)|Ayala Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Ayala Pharmaceuticals Inc Shares Outstanding|Ayala Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Ayala Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Ayala Pharmaceuticals Inc Payout Ratio|Ayala Pharmaceuticals Inc Quick Ratio (Quarterly)|Ayala Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Ayala Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Ayala Pharmaceuticals Inc Effective Tax Rate (TTM)|Ayala Pharmaceuticals Inc Return on Equity|Ayala Pharmaceuticals Inc Net Income (TTM) (USD)|Ayala Pharmaceuticals Inc Revenue (TTM) (USD)|Ayala Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Ayala Pharmaceuticals Inc Revenue (Quarterly) (USD)|Ayala Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Ayala Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Ayala Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Ayala Pharmaceuticals Inc Net Income (Quarterly) (USD)|Ayala Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Ayala Pharmaceuticals Inc Price (USD)|Ayala Pharmaceuticals Inc Total Return Price (USD)|Ayala Pharmaceuticals Inc Enterprise Value (USD)|Ayala Pharmaceuticals Inc 30-Day Average Daily Volume|Ayala Pharmaceuticals Inc 1 Year Price Returns (Daily)||
new_adrs_0322_0825|AYLA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_adrs_0322_0825|AYLA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_adrs_0322_0825|AYLA|5|91.2857142857|91.2857142857||91.2857142857||91.2857142857|91.2857142857|91.2857142857||91.2857142857|91.2857142857||1.44776119403|91.4|1.44776119403|91.4|1.44776119403||1.44572748268|1.44918032787|91.2857142857|1.44776119403|91.4|15.2093023256|91.2857142857|91.2857142857|91.2857142857|91.25|91.4|30.375|30.3333333333|91.25|30.2857142857|91.4|91.2|91.4|32.1176470588||91.2857142857|91.2857142857|91.2857142857|91.4|91.4444444444|91.2857142857|91.25|91.2857142857|91.2857142857||91.4|91.4|91.4|91.4|91.4|91.4|1.44776119403|1.44776119403|1.44776119403|1.44772727273|1.43778801843||
new_adrs_0322_0825|AYLA|6|7|7||7||7|7|7||7|7||469|5|469|5|469||433|305|7|469|5|43|7|7|7|4|5|8|9|4|14|10|5|10|17||7|7|7|10|9|7|4|7|7||10|10|10|10|10|10|469|469|469|440|217||
new_adrs_0322_0825|AYLA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_adrs_0322_0825|AYLA|201903||||||||||||||||||||||||||||||||||8.5803||-0.4125||||||-0.4125|||||||0.265||0.848|-3.464|-3.539|0.136|||||||
new_adrs_0322_0825|AYLA|201906||||||||||||||||||||||||||||||||||8.5803||-0.4409||||||-0.4409|||||||0.852|0.692|1.021|-3.67|-3.783|0.098|||||||
new_adrs_0322_0825|AYLA|201909||||||||||||||||||||||||||||||||||8.5803||-0.5882||||||-0.5882|||||||0.845|0.36|0.945|-5.008|-5.047|-0.051|||||||
new_adrs_0322_0825|AYLA|201912|17.694|16.725||1.421||58.974|5.302|53.672||-38.92|-40.741||||||||||||||0.469|2.922|0.051|||||||8.5803|29|-0.632|||12.1133||3.2429|-0.632||-1.75||-17.792|2.334||0.372|-0.003|1.522|-5.344|-5.423|0.042|||||||
new_adrs_0322_0825|AYLA|202003|11.45|10.055||1.388||60.387|6.466|53.921||-45.225|-47.339||57.8631||-9.3875||46.4856|||||||0.0616|1.001|6.466|0.051|||||||12.1133|31|-0.5447|12.4466||12.1133||1.7099|-0.5447||-1.7172||-20.851|3.07||1.001||1.311|-6.477|-6.598|-0.038|15.08|15.08|177.6397||||
new_adrs_0322_0825|AYLA|202006|58.627|57.355||1.365||6.319|5.785|0.534||53.956|-54.051||21.6117|-2.9655|-3.3396|1.17|29.6319||2.37||||-40.9536|0.0157|0.836|5.785|0.128||1|||||9.0186|31|-0.74|12.6608||12.6608||10.0589|-0.74|-52.369|-1.6152||-23.78|3.263||1.045||1.546|-6.573|-6.712|0.04|10.1|10.1|70.5191|33458.8667||13.33|11.85
new_adrs_0322_0825|AYLA|202009|51.751|48.749||1.357||6.461|5.999|0.462||46.932|-61.489||31.6033|-3.7145|-3.9093|1.8207|39.6765||3.11||||-36.0741|0.0965|0.589|5.999|0.127|-625.2404|1|||-625.2404||12.6645|31|-0.59|12.6702||12.6702||8.2244|-0.59|-0.285|-1.7654|-625.2404|-26.171|3.076||0.658||1.862|-7.323|-7.438|-0.04|11.52|11.52|97.2117|10646||11.39|9.75
new_adrs_0322_0825|AYLA|202012|44.24|42.025||1.283||7.43|6.877|0.553||38.398|-70.887||26.4263|-3.2505|-3.5521|2.1382|34.5283||3.6464|-0.1649|||-37.597|0.273|0.681|3.726|0.128|-273.3538|1|||-273.3538|24.8587|12.7599|34|-0.73|12.7284||12.7284||6.21|-0.73|0.013|-1.43|-273.3538|-30.146|3.708||1.004||2.652|-9.348|-9.398|0.094|11.0001|11.0001|97.9887|14280.4667||12.99|17.15
new_adrs_0322_0825|AYLA|202103|57.85|56.03||1.119||6.199|5.694|0.505||53.034|-80.455||23.5229|-2.6147|-2.8091|1.4618|35.071||2.6892|-0.1446|||-53.4667|0.7848|0.169|5.694|0.131|-112.5667|1||-0.6153|-112.5667|27.1929|12.8883|31|-0.74|13.0722||13.0722||9.8699|-0.74|-23.612|-1.6951|-112.5667|-33.116|3.681||0.974||2.303|-9.32|-9.568|-0.092|10.91|10.91|86.5877|21897.7333|-36.4424|10.63|9.54
new_adrs_0322_0825|AYLA|202106|47.01|44.412||1.192||5.712|5.21|0.502||42.76|-91.296||26.201|-2.3897|-2.4025|1.8362|39.5437||3.1201|-0.2978|||-17.8576|1.0773|0.929|5.21|0.131|-79.2177|1|1|-0.8024|-79.2177|27.9472|14.4174||-0.75|13.0929||13.0929||8.7027|-0.75|0.059|-1.568|-79.2177|-37.245|3.397||0.761||2.536|-10.679|-10.841|-0.022|10.19|10.19|89.0047|13020.2333|0.8911|12.5|12.67
new_adrs_0322_0825|AYLA|202109|44.324|40.84||1.148||6.36|5.867|0.493||39.384|-101.092||33.5345|-2.8485|-3.0072|2.4661|45.9712||3.9013|-0.2492|||-19.0797|0.9171|0.373|5.867|0.135|-89.7995|1|3|-0.7595|-89.7995|31.4749|14.4836||-0.68|13.5494||13.5494||7.0245|-0.68|-5.776|-1.6087|-89.7995|-39.603|3.364||0.625||2.198|-9.629|-9.796|-0.063|11.34|11.34|112.8102|33259|-1.5625|10.98|9.5
new_adrs_0322_0825|AYLA|202112|||||||||||||23.1122||-2.0726||34.4987||3.0111|-0.187||||0.4002||||||4|-0.3078||44.593||||||||||||||||||||||8.51|8.51|77.7494|26589.6333|-22.6371|5.68|3.97
new_adrs_0322_0825|AYLA|202203|||||||||||||4.2225||-0.3787||16.0129||1.3976|-0.0868|||||||||||||||||||||||||||||||||||3.95|3.95|14.2044|19583.6|-69.0439||